thymine has been researched along with Pseudomyxoma Peritonei in 1 studies
Pseudomyxoma Peritonei: A peritoneal adenocarcinoma characterized by build-up of MUCUS in the PERITONEAL CAVITY. Mucus secreting cells may attach to the peritoneal lining and continue to secrete mucus. The majority of cases represent tumor spread from a primary low-grade mucinous neoplasm of the APPENDIX (NCI Thesaurus).
Excerpt | Relevance | Reference |
---|---|---|
"Pseudomyxoma peritonei is a rare disease with a reported prevalence of about 1-3 per million people annually." | 5.62 | A case of pseudomyxoma peritonei successfully treated with trifluridine/tipiracil (TAS-102) and bevacizumab after palliative debulking surgery. ( Gohda, Y; Hayama, N; Hirano, S; Igari, T; Miyazaki, H; Shimizu, S; Yano, H, 2021) |
"Pseudomyxoma peritonei is a rare disease with a reported prevalence of about 1-3 per million people annually." | 1.62 | A case of pseudomyxoma peritonei successfully treated with trifluridine/tipiracil (TAS-102) and bevacizumab after palliative debulking surgery. ( Gohda, Y; Hayama, N; Hirano, S; Igari, T; Miyazaki, H; Shimizu, S; Yano, H, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hirano, S | 1 |
Gohda, Y | 1 |
Miyazaki, H | 1 |
Hayama, N | 1 |
Shimizu, S | 1 |
Igari, T | 1 |
Yano, H | 1 |
1 other study available for thymine and Pseudomyxoma Peritonei
Article | Year |
---|---|
A case of pseudomyxoma peritonei successfully treated with trifluridine/tipiracil (TAS-102) and bevacizumab after palliative debulking surgery.
Topics: Bevacizumab; Cytoreduction Surgical Procedures; Drug Combinations; Humans; Male; Middle Aged; Perito | 2021 |